Jesse Dong, PhDVice President, Peptide Chemistry at Neon Therapeutics
Jesse Z. Dong, Ph.D., is Vice President, Peptide Chemistry at Neon Therapeutics. At Neon he is leading the peptide chemistry activities of developing neoantigen cancer vaccines, process development and tech support for cGMP manufacturing. Prior to joining Neon, Jesse worked at Ipsen as Vice President of Compound Discovery, heading global Peptide Chemistry Division and leading peptide-based R&D programs. He is the inventor of TYMLOS™ (Abaloparatide), Setmelanotide, Relamorelin, and Taspoglutide and a co-inventor of TBR-760 and TBR-065. Jesse is named inventor or co-inventor in 68 issued US patents and over 80 US patent applications. He is a co-author of over 150 publications and abstracts.